Gore Tex Implants in the Treatment of Atrophic Rhinitis

Atrophic Rhinitis Clinical Trial

— RA  

Official title:

Gore Tex Implants in the Treatment of Atrophic Rhinitis

Clinical Trial Details — Status: Suspended

Administrative data

• NCT number: NCT00832403
• Other study ID #: Rinite Atrófica cep/hfr
• Status: Suspended
• Phase: N/A
• First received: January 27, 2009
• Last updated: January 29, 2009
• Start date: November 2006

Study information

• Verified date: January 2009
• Source: Hospital Felicio Rocho
• Contact: n/a
• Is FDA regulated: No
• Health authority: Brazil: Ministry of Health
• Study type: Observational

Clinical Trial Summary

This is a retrospective study, involving patients with atrophic rhinitis, that underwent Gore tex® implants in the nasal fossa.

The Fetid Rhinitis or Atrophic Ozena is a chronic illness characterized by yellowish secretion in the initial phase and the other phases with fetid crusts and atrophy of the mucous bone covering. Diverse theories exist that try to explain the appearance of this pathology, such as: hereditary factors, immunological alterations, viral infection and nutritional lack. Currently, its etiology remains unknown. As there isn't any ideal treatment already established, this technique improves the options of treatment.

All patients have improved after the procedure.

Description:

Data about 5 patients that underwent surgery to implant polytetrafluoroethylene in the nasal fossa was collect. The symptoms and complications were described.

Recruitment information / eligibility

• Status: Suspended
• Enrollment: 5
• Est. primary completion date: February 2008
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Symptoms of atrophic rhinitis, with previous clinical treatment without good results

Exclusion Criteria:

• Patients with mental illness

Study Design

Observational Model: Case-Only, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Atrophic Rhinitis
• Atrophy
• Rhinitis

Intervention

Other:
• implants of polytetrafluoroethylene in tha nasal fossa
surgical implants of polytetrafluoroethylene in the nasal fossa

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Hospital Felicio Rocho

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	improvement of fetid crusts and atrophy of the mucous bone covering		after surgery recovery	No
Secondary	lack of side effects such as infection		after the treatment	No